Allergan Fined $15M Over Disclosure Failures
The SEC says the drug maker failed to timely inform investors about its merger talks with Salix and Actavis.
Salix CFO Resigns as Board Reviews Inventory Accounting
Are high levels of inventory at wholesalers indicative of improper accounting of sales?
Salix Calls Off Tax Inversion Deal
The Treasury Department's recent anti-inversion measures claim their first victim — Salix Pharmaceuticals' plan to merge with Italy-based Cosmo.